Abbott Laboratories ABT 107.96 +212.85% NYQ · Healthcare
Open terminal

Abbott Laboratories (abt)

Unlock full data in Terminal →

ABT News

Live headlines and press releases for Abbott Laboratories load in the terminal.

Company news & press releases is available in Vest Terminal for Professional and Enterprise subscribers.

Abbott Laboratories FAQ

What does Abbott Laboratories (ABT) do?

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers…

What is ABT's P/E ratio?

Abbott Laboratories has a trailing P/E of 34.27× based on publicly available market data.

Does ABT pay a dividend?

Indicated dividend yield: 2.4%. Confirm ex-dates and payout history in Vest Terminal.

What sector is ABT in?

Abbott Laboratories is classified in Healthcare (Medical Devices) on NYQ.

What is ABT's market capitalization?

Approximate market cap: $188.05B.

What are the main risks for ABT?

Standard market, competitive, and execution risks apply; see the Risks section.

What are the strengths of ABT?

Potential positives include revenue growth of 13.0% year-over-year, gross margin of 56.8% supports competitive unit economics.

Where can I get analyst estimates for ABT?

Consensus estimates, price targets, and detailed analyst data for Abbott Laboratories are available to Professional subscribers in Vest Terminal — not on this public summary page.